IndraLab

Statements

BAP1 inhibits Malignant Mesothelioma. 1 / 1

| 1

reach

"In this study, we observed BAP1 expression loss in five of eight epithelioid-type MM cases (62.5%), while also observing loss in both sarcomatoid and epithelioid components in five of 13 biphasic-type MM cases (38.5%)."

33153245

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

BAP1 inhibits Malignant Mesothelioma. 1 / 1

INDRA sources:

Databases

Reading